Results of Medical Research Council Phase II Study of Low Dose Cisplatin and Methotrexate in the Primary Treatment of Locally Advanced (T3 and T4) Transitional Cell Carcinoma of the Bladder-Reference-Cited by-同舟云学术

Results of Medical Research Council Phase II Study of Low Dose Cisplatin and Methotrexate in the Primary Treatment of Locally Advanced (T3 and T4) Transitional Cell Carcinoma of the Bladder

Published:1991-08 Issue:2 Volume:68 Page:162-168
ISSN:0007-1331
Container-title:British Journal of Urology
language:en
Short-container-title:

Author:

ROBERTS J. T.,FOSSA SOPHIE D.,RICHARDS B.,KAYE S. B.,WHITE E. F.,ROBINSON M. C.,USCINSKA B.,PARMAR M. K. B.

Publisher

Wiley

Subject

Urology,Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.1991.tb15287.x/fullpdf

Reference18 articles.

1. T3 bladder cancer-the case for salvage cystectomy;Blandy;Br. J. Urol.,1980

2. Treatment of T3 bladder cancer: controlled trial of preoperative radiotherapy and radical cystectomy versus radical radiotherapy. Second report and review;Bloom;Br. J. Urol.,1982

3. Cis-platin and methotrexate in the treatment of transitional cell carcinoma of the urinary tract;Carmichael;Br. J. Urol.,1985

4. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy;Duncan;Radiother. Oncol.,1986

5. Cis-diamminedichloro-platinum (DDP) as initial treatment of invasive bladder cancer;Fagg;Br. J. Urol.,1984

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder Cancer;Clinical Radiation Oncology;2017-05-05

2. Bladder Cancer;Clinical Radiation Oncology;2016

3. Grundlagen der systemischen Therapie;Uroonkologie;2014

4. Bladder Cancer;Clinical Radiation Oncology;2012

5. Organ-sparing strategies in the management of invasive bladder cancer;Expert Review of Anticancer Therapy;2009-12